ESH 3rd How to Diagnose and Treat Multiple Myeloma: virtual tour of the E-Conference platform

ESH 3rd How to Diagnose and Treat Multiple Myeloma: virtual tour of the E-Conference platform

Translational Research E-Conference on Multiple Myeloma: Virtual tour of the E-Conference platformПодробнее

Translational Research E-Conference on Multiple Myeloma: Virtual tour of the E-Conference platform

ESH How to Diagnose and Treat LYMPHOMA: virtual tour of the E-Conference platformПодробнее

ESH How to Diagnose and Treat LYMPHOMA: virtual tour of the E-Conference platform

Welcome to the ESH How to Diagnose and Treat Acute Leukaemia 2020Подробнее

Welcome to the ESH How to Diagnose and Treat Acute Leukaemia 2020

How should smoldering multiple myeloma be monitored?Подробнее

How should smoldering multiple myeloma be monitored?

Translational Research E-Conference: Bone Marrow Failure Disorders: virtual tour of the platformПодробнее

Translational Research E-Conference: Bone Marrow Failure Disorders: virtual tour of the platform

ESH 2nd Translational Research E-Conference on Chronic Lymphocytic Leukaemia: virtual tourПодробнее

ESH 2nd Translational Research E-Conference on Chronic Lymphocytic Leukaemia: virtual tour

Translational Research E-Conference on Multiple Myeloma: virtual tour of the E-Conference platformПодробнее

Translational Research E-Conference on Multiple Myeloma: virtual tour of the E-Conference platform

Welcome video: 3rd ESH How to Diagnose and Treat Multiple Myeloma E-ConferenceПодробнее

Welcome video: 3rd ESH How to Diagnose and Treat Multiple Myeloma E-Conference

ESH How to Diagnose and Treat Leukaemia E-Conference: virtual tourПодробнее

ESH How to Diagnose and Treat Leukaemia E-Conference: virtual tour

Epidemiology of Multiple Myeloma and Related Precursor States - A Model for Early DetectionПодробнее

Epidemiology of Multiple Myeloma and Related Precursor States - A Model for Early Detection

Treatment options for high-risk myelomaПодробнее

Treatment options for high-risk myeloma

How I Manage CAR-T Therapies and Bispecific Antibodies for My Patients: welcome video. #ESHCART2021Подробнее

How I Manage CAR-T Therapies and Bispecific Antibodies for My Patients: welcome video. #ESHCART2021

Managing multiple myeloma patients with del(17p)Подробнее

Managing multiple myeloma patients with del(17p)

Challenges in myeloma treatment in the UKПодробнее

Challenges in myeloma treatment in the UK

ESH 3rd How to Diagnose and Treat Acute Leukaemias: virtual tourПодробнее

ESH 3rd How to Diagnose and Treat Acute Leukaemias: virtual tour

Myeloma: honing the immune system, building the armamentariumПодробнее

Myeloma: honing the immune system, building the armamentarium

How to identify and mitigate neurologic AEs when treating with CAR-T and T-cell engagers?Подробнее

How to identify and mitigate neurologic AEs when treating with CAR-T and T-cell engagers?

Real-world analysis of treatment patterns and outcomes in newly diagnosed myelomaПодробнее

Real-world analysis of treatment patterns and outcomes in newly diagnosed myeloma

Real-world treatment patterns & outcomes among patients with triple-class exposed myelomaПодробнее

Real-world treatment patterns & outcomes among patients with triple-class exposed myeloma